Tags: Drug.

Pramlintide (Symlin) is a relatively new adjunct for diabetes (both type 1 and 2) developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca). Pramlintide is delivered as an acetate salt.

Pramlintide_sequence.svg
ATC prefix
A10
ATC suffix
BX05
Bioavailability
30.0
CAS number
151126-32-8
DrugBank
DB01278
FDA UNII code
D3FM8FA78T
PubChem
16132446

Loading...

This page contains content from the copyrighted Wikipedia article "Pramlintide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.